文献速递乳腺外科围术期管理与 ERAS

保乳手术联合放疗与乳房切除术后的生存比较:随机麻醉试验中的倾向性评分分析

Survival after breast-conserving surgery and radiotherapy versus mastectomy: propensity score analyses within a randomized anaesthesiology trial.
PubMed 文献 · Br J Surg · 2026-01-01

本研究基于随机CAN试验队列,纳入830例乳腺癌患者(601例保乳+放疗,229例乳房切除术),比较总生存(OS)和乳腺癌特异性生存(BCSS)。校正及倾向性评分分析显示两组BCSS无显著差异(校正HR 1.02,95%CI 0.43-2.42),OS差异可能反映选择偏倚。

要点

  • 保乳+放疗与乳房切除术的BCSS在校正及倾向性评分分析中无显著差异。
  • 乳房切除术组OS较差可能源于合并症负担更高的选择偏倚。
  • 未校正分析中乳房切除术组BCSS较差(HR 2.27,95%CI 1.20-4.30)。

核心结论

  • 在尽可能接近随机试验的设计下,保乳+放疗与乳房切除术的BCSS无显著差异。
  • OS差异可能反映合并症负担更高的患者被选择至乳房切除术的隐匿性偏倚。

研究设计与样本

  • 患者队列来自随机CAN试验,该试验比较乳腺癌手术中静脉与吸入麻醉。
  • 排除肿瘤>30 mm、肿瘤<10 mm及未接受放疗的保乳患者,最终纳入830例女性。
  • 601例接受保乳+放疗(中位年龄64岁),229例接受乳房切除术(中位年龄68岁)。
  • 采用多变量Cox回归和三种不同的倾向性评分模型估计OS和BCSS。

主要发现

  • 乳房切除术组患者合并症更多且肿瘤特征更不利。
  • 乳房切除术在未校正、校正及三种倾向性评分分析中的两种里与显著较差的OS相关。
  • 未校正分析中乳房切除术组BCSS较差,HR为2.27(95%CI 1.20-4.30)。
  • 校正及三种倾向性评分分析中BCSS组间相等,校正HR为1.02(95%CI 0.43-2.42)。

临床怎么用

  • 对于符合保乳条件且接受放疗的患者,保乳+放疗与乳房切除术的BCSS相当。
  • 解读观察性数据中乳房切除术的生存劣势时,需考虑合并症分布的选择偏倚。

局限性

  • 原文未明确报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Large randomized studies show equivalent survival after breast-conserving surgery (BCS) + adjuvant radiotherapy (RT) and mastectomy. In contrast, more recent observational studies suggest BCS + RT to be superior, but it is questionable whether patients in these treatment arms are comparable. Here, overall survival (OS) and breast cancer-specific survival (BCSS) after BCS + RT and mastectomy are compared within a randomized trial comparing intravenous and inhalation anaesthesia during breast cancer surgery. METHODS: The patient cohort was recruited from the randomized CAN-study. Patients with tumours >30 mm, patients with tumours <10 mm, and patients who underwent BCS without RT were excluded. OS and BCSS were estimated using multivariable Cox regression analyses and three different propensity score models. RESULTS: The final study cohort included 830 women, of whom 601 underwent BCS + RT (median age 64 years) and 229 underwent mastectomy (median age 68 years). Women who underwent mastectomy had more co-morbidities and more unfavourable tumour characteristics. Mastectomy was associated with significantly less favourable OS in unadjusted, adjusted, and two of the three propensity score analyses. BCSS was inferior in the mastectomy group in the unadjusted analysis, with an HR of 2.27 (95% c.i. 1.20 to 4.30). In the adjusted and three propensity score analyses, BCSS was equal in the treatment groups, with an adjusted HR of 1.02 (95% c.i. 0.43 to 2.42). CONCLUSION: In this study, which was designed to approximate a randomized trial as closely as possible, no significant difference in BCSS was observed between BCS + RT and mastectomy. Differences in OS likely reflect occult selection bias of patients with higher co-morbidity burden to mastectomy.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Wadsten C, Berglund A, Söderberg E, et al. Survival after breast-conserving surgery and radiotherapy versus mastectomy: propensity score analyses within a randomized anaesthesiology trial. Br J Surg. 2026. PMID: 41954954. doi:10.1093/bjs/znag036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。